|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brennan MF: Adjuvant therapy following
resection for pancreatic adenocarcinoma. Surg Oncol Clin N Am.
13:555–566. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stojadinovic A, Hoos A, Brennan MF and
Conlon KC: Randomized clinical trials in pancreatic cancer. Surg
Oncol Clin N Am. 11:207–229. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wolfgang CL, Herman JM, Laheru DA, Klein
AP, Erdek MA, Fishman EK and Hruban RH: Recent progress in
pancreatic cancer. CA Cancer J Clin. 63:318–348. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamamura K, Kasuya H, Sahin TT, Tan G,
Hotta Y, Tsurumaru N, Fukuda S, Kanda M, Kobayashi D, Tanaka C, et
al: Combination treatment of human pancreatic cancer xenograft
models with the epidermal growth factor receptor tyrosine kinase
inhibitor erlotinib and oncolytic herpes simplex virus HF10. Ann
Surg Oncol. 21:691–698. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nikfarjam M, Yeo D, He H, Baldwin G, Fifis
T, Costa P, Tan B, Yang E, Wen S and Christophi C: Comparison of
two syngeneic orthotopic murine models of pancreatic
adenocarcinoma. J Invest Surg. 26:352–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Troiani T, Schettino C, Martinelli E,
Morgillo F, Tortora G and Ciardiello F: The use of xenograft models
for the selection of cancer treatments with the EGFR as an example.
Crit Rev Oncol Hematol. 65:200–211. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bimonte S, Barbieri A, Palma G, Luciano A,
Rea D and Arra C: Curcumin inhibits tumor growth and angiogenesis
in an orthotopic mouse model of human pancreatic cancer. BioMed Res
Int. 2013:8104232013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nangami GN, Watson K, Parker Johnson K,
Okereke KO, Sakwe A, Thompson P, Frimpong N and Ochieng J: Fetuin-A
(α2HS-glycoprotein) is a serum chemo-attractant that also promotes
invasion of tumor cells through Matrigel. Biochem Biophys Res
Commun. 438:660–665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Büchler P, Reber HA, Roth MM, Shiroishi M,
Friess H and Hines OJ: Target therapy using a small molecule
inhibitor against angiogenic receptors in pancreatic cancer.
Neoplasia. 9:119–127. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hakkarainen T, Särkioja M, Lehenkari P,
Miettinen S, Ylikomi T, Suuronen R, Desmond RA, Kanerva A and
Hemminki A: Human mesenchymal stem cells lack tumor tropism but
enhance the antitumor activity of oncolytic adenoviruses in
orthotopic lung and breast tumors. Hum Gene Ther. 18:627–641. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Poplin E, Feng Y, Berlin J, Rothenberg ML,
Hochster H, Mitchell E, Alberts S, O'Dwyer P, Haller D and Catalano
P: Phase III, randomized study of gemcitabine and oxaliplatin
versus gemcitabine (fixed-dose rate infusion) compared with
gemcitabine (30-minute infusion) in patients with pancreatic
carcinoma E6201: A trial of the Eastern Cooperative Oncology Group.
J Clin Oncol. 27:3778–3785. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McAllister SS and Weinberg RA: Tumor-host
interactions: A far-reaching relationship. J Clin Oncol.
28:4022–4028. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Colucci G, Labianca R, Di Costanzo F,
Gebbia V, Cartenì G, Massidda B, Dapretto E, Manzione L, Piazza E,
Sannicolò M, et al: Gruppo Oncologico Italia Meridionale (GOIM);
Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente
(GISCAD); Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC):
Randomized phase III trial of gemcitabine plus cisplatin compared
with single-agent gemcitabine as first-line treatment of patients
with advanced pancreatic cancer: The GIP-1 study. J Clin Oncol.
28:1645–1651. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cui L, Chen P, Tan Z, Li W and Dong Z:
Hemostatic gelatin sponge is a superior matrix to matrigel for
establishment of LNCaP human prostate cancer in nude mice.
Prostate. 72:1669–1677. 2012. View Article : Google Scholar : PubMed/NCBI
|
